USBC, Inc. (USBC) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cotizando a $, USBC, Inc. (USBC) es una empresa del sector Technology valorada en 0. Calificado con 43/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.
Ultimo analisis: 15 mar 2026Perfil Tecnológico y Posición Competitiva de USBC, Inc. (USBC)
USBC, Inc. is a technology company focused on digital financial technologies and non-invasive health monitoring research. The company develops digital assets, banking solutions, and material analysis technologies, positioning itself in the evolving landscape of fintech and health tech within the scientific and technical instruments industry.
Tesis de Inversión
USBC, Inc. presents a unique investment opportunity within the intersection of fintech and health tech. The company's focus on digital assets, banking solutions, and non-invasive health monitoring positions it to capitalize on the growing demand for innovative financial and healthcare technologies. With a market capitalization of $0.13 billion and a debt-to-equity ratio of 0.35, USBC demonstrates a moderate level of financial leverage. However, the company's negative return on equity (-46.6%) and negative free cash flow ($-0.00B) highlight the challenges it faces in achieving profitability and sustainable growth. Key catalysts include the successful development and commercialization of its non-invasive health monitoring technologies and the expansion of its digital financial services offerings. Potential risks include regulatory hurdles in the fintech sector and competition from established players in both the financial and healthcare industries.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market capitalization of $0.13 billion indicates the company's current valuation in the market.
- Debt-to-equity ratio of 0.35 suggests a moderate level of financial leverage.
- Negative return on equity of -46.6% reflects challenges in generating profits from shareholder equity.
- Negative free cash flow of $-0.00B indicates the company is currently not generating positive cash flow from its operations.
- Beta of 1.67 suggests the stock is more volatile than the market average.
Fortalezas
- Innovative technology in digital finance and health monitoring
- Expertise in electromagnetic energy-based material analysis
- Potential for high growth in emerging markets
- Strong focus on research and development
Debilidades
- Negative return on equity
- Negative free cash flow
- Limited market presence compared to established competitors
- Dependence on successful commercialization of new technologies
Catalizadores
- Upcoming: Launch of new digital financial services platform.
- Upcoming: Completion of clinical trials for non-invasive health monitoring device.
- Ongoing: Expansion of strategic partnerships with financial institutions.
- Ongoing: Development of AI-driven solutions for personalized financial advice.
Riesgos
- Potential: Regulatory changes impacting the fintech industry.
- Potential: Competition from established players in the financial and healthcare sectors.
- Ongoing: Challenges in achieving profitability and sustainable growth.
- Ongoing: Dependence on successful commercialization of new technologies.
Oportunidades de crecimiento
- Expansion of Digital Financial Services: USBC, Inc. can expand its digital financial services by developing new products and services, such as cryptocurrency wallets, decentralized lending platforms, and blockchain-based payment systems. The global fintech market is projected to reach $305 billion by 2025, offering significant growth potential. Timeline: Ongoing.
- Commercialization of Non-Invasive Health Monitoring Technologies: The company's research in non-invasive health monitoring could lead to the development of wearable devices and remote monitoring systems for chronic diseases. The global remote patient monitoring market is expected to reach $175 billion by 2027, presenting a substantial market opportunity. Timeline: Upcoming.
- Strategic Partnerships: USBC, Inc. can form strategic partnerships with established financial institutions and healthcare providers to expand its market reach and access new customer segments. Collaborations with major players in these industries can accelerate the adoption of its technologies and enhance its credibility. Timeline: Ongoing.
- Geographic Expansion: The company can expand its operations beyond the United States to target international markets with high growth potential in fintech and health tech. Emerging economies in Asia and Latin America offer significant opportunities for digital financial services and remote healthcare solutions. Timeline: Upcoming.
- Development of AI-Driven Solutions: USBC, Inc. can leverage artificial intelligence and machine learning to enhance its products and services, such as personalized financial advice, predictive health analytics, and automated fraud detection. The AI in healthcare market is projected to reach $34 billion by 2027, indicating a growing demand for AI-powered solutions. Timeline: Ongoing.
Oportunidades
- Expansion into new geographic markets
- Strategic partnerships with major financial institutions
- Increased adoption of digital financial services
- Growing demand for non-invasive health monitoring solutions
Amenazas
- Regulatory hurdles in the fintech sector
- Competition from established players in the financial and healthcare industries
- Rapid technological changes
- Economic downturns affecting consumer spending
Ventajas competitivas
- Proprietary technology in non-invasive health monitoring.
- Expertise in digital asset development and management.
- Strategic partnerships with key players in the financial and healthcare sectors.
Acerca de USBC
USBC, Inc., formerly known as Know Labs, Inc., was incorporated in 1998 and is based in Reno, Nevada. The company underwent a name change in August 2025, reflecting its strategic shift and expanded focus within the digital financial technologies sector. USBC, Inc. operates in the United States, developing transformative financial services, including digital assets and banking solutions. These solutions aim to leverage technology to enhance financial accessibility and efficiency for consumers and businesses. In addition to its fintech initiatives, USBC, Inc. is involved in non-invasive health monitoring research. This segment focuses on developing technologies that can monitor health metrics without requiring invasive procedures. The company also specializes in identifying and measuring materials or analytes using electromagnetic energy. This technology is designed to detect, record, identify, and measure the signature of various materials, with potential applications across multiple industries, including healthcare, environmental monitoring, and materials science. USBC, Inc. aims to integrate these diverse technological capabilities to create synergistic solutions that address unmet needs in both the financial and healthcare sectors. The company's strategy involves continuous innovation and strategic partnerships to expand its market reach and technological capabilities.
Qué hacen
- Develops digital assets and banking solutions.
- Conducts research in non-invasive health monitoring.
- Identifies and measures materials using electromagnetic energy.
- Offers transformative financial services.
- Creates technologies for detecting and recording material signatures.
- Provides solutions for analyzing materials and analytes.
Modelo de Negocio
- Develops and licenses digital financial technologies.
- Generates revenue through the sale of health monitoring devices.
- Offers subscription-based access to its material analysis technologies.
Contexto de la Industria
USBC, Inc. operates within the technology sector, specifically in the scientific and technical instruments industry. This industry is characterized by rapid technological advancements and increasing demand for innovative solutions in healthcare and finance. The fintech market is experiencing substantial growth, driven by the adoption of digital payment systems and the increasing demand for decentralized financial services. Similarly, the health tech market is expanding due to the growing need for remote monitoring and non-invasive diagnostic tools. USBC, Inc. aims to capitalize on these trends by developing integrated solutions that address unmet needs in both sectors. The company faces competition from established players and emerging startups, requiring a focus on differentiation and strategic partnerships to gain market share.
Clientes Clave
- Financial institutions seeking digital transformation solutions.
- Healthcare providers looking for non-invasive monitoring tools.
- Research institutions requiring material analysis technologies.
Finanzas
Gráfico e información
Precio de la acción de USBC, Inc. (USBC): Price data unavailable
Últimas noticias
-
12 Health Care Stocks Moving In Friday's After-Market Session
benzinga · 20 mar 2026
-
12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga · 10 mar 2026
-
12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga · 18 feb 2026
-
12 Health Care Stocks Moving In Friday's After-Market Session
benzinga · 6 feb 2026
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para USBC.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para USBC.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de USBC en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Clasificación
Industria Scientific & Technical InstrumentsÚltimas Noticias
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
Acciones de USBC, Inc.: Preguntas Clave Respondidas
¿Cuáles son los factores clave para evaluar USBC?
USBC, Inc. (USBC) actualmente tiene una puntuación IA de 43/100, indicando puntuación baja. Fortaleza clave: Innovative technology in digital finance and health monitoring. Riesgo principal a monitorear: Potential: Regulatory changes impacting the fintech industry.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de USBC?
USBC actualmente puntúa 43/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de USBC?
Los precios de USBC se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre USBC?
La cobertura de analistas para USBC incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en USBC?
Las categorías de riesgo para USBC incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Regulatory changes impacting the fintech industry.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de USBC?
La relación P/E para USBC compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está USBC sobrevalorada o infravalorada?
Determinar si USBC, Inc. (USBC) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de USBC?
USBC, Inc. (USBC) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Financial data is limited, impacting the depth of analysis.
- AI analysis is pending, which could provide further insights.